Drug Database
Back to search

Netherlands· NL-d750e2742305

Tolbutamide Aurobindo 500 mg, tabletten

A tolbutamide product containing tolbutamide, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 4 of our 19 countries.

ATC A10BB03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedTolbutamide Aurobindo 500 mg, tablett…ATCA10BB03REGISTER NO.NL-d750e2742305PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tolbutamideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tolbutamide is registered in 4 of 19 countries.

Countries holding a registration under ATC A10BB03 (tolbutamide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 1 of them publish a price we can compare per daily dose
Search tolbutamide products by name

Tolbutamide · ATC A10BB03

4 / 19 countries

  • Finlandprice
  • Japan
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TOLBUTAMIDE
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
A10BB03
ATC class
Tolbutamide
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    55003

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

556 interactions on record for tolbutamide.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tolbutamide against other medicinesHow interaction checks work

Tolbutamide · interactions on record

556 records

  • 20 severe
  • 463 moderate
  • 55 minor
  • 18 info

Most severe, free to view

  • MiconazoleA07AC01severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tolbutamide in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tolbutamide products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • United Kingdom (Northern Ireland) · Tolbutamide Genethics Europe, Tolbutamide Kent Pharmaceuticals

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8f667a3d-2e30-4fe2-8f21-f100e260cd00
GET /v1/drugs/8f667a3d-2e30-4fe2-8f21-f100e260cd00?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h55003_smpc.pdf",
  "strength": null,
  "atc_label": "Tolbutamide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg55003",
  "excipients": [
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 90 (E 1201)",
    "TALK (E 553b)"
  ],
  "substances": [
    "TOLBUTAMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h55003.pdf",
  "authorised_at": "1992/12/09",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "55003",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tolbutamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console